Valderm

ValDerm, LLC was a privately held biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative therapies for dermatological conditions. Founded by industry veterans with extensive experience in dermatology drug development, the company specialized in identifying and advancing early-stage assets for inflammatory skin diseases. In March 2019, ValDerm was acquired by Novan, Inc. to bolster Novan's dermatology pipeline and leverage ValDerm's strategic and operational expertise. The acquisition included a portfolio of early-stage assets, including topical formulations of small molecule inhibitors targeting key inflammatory pathways.